IAIM
SEEL

International Assets Investment Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

International Assets Investment Management’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19
Closed -$14.5K – 846
2023
Q3 		$14.5K Buy
19
+3
+19% +$12.9K ﹤0.01% 612
2023
Q2 		$75.6K Sell
16
-2
-11% -$6.94K 0.01% 581
2023
Q1 		$47.2K Buy
+18
New +$52.7K 0.01% 683

Other funds holding SEEL

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

International Assets Investment Management's SEEL Position: Q4 2023 in Review

International Assets Investment Management sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2023, closing a stake of 19 shares — an estimated $14.5K sold.

International Assets Investment Management first reported a position in SEEL in Q1 2023 and held it in 3 quarters. The position peaked at $75.6K in Q2 2023. 32 funds tracked by Wall St. Rank hold SEEL as of Q4 2023.

  • International Assets Investment Management reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • International Assets Investment Management sold 19 Seelos Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $14.5K.
  • International Assets Investment Management first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • International Assets Investment Management's Seelos Therapeutics, Inc. Common Stock position peaked at $75.6K in Q2 2023.
  • 32 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2023.

Based on International Assets Investment Management's 13F filing for Q4 2023, filed 24 Jan 2024.